Immunohistochemical analysis of NSCLC detected caveolin-1 expression in 15-30% of specimens and the loss of the caveolin-1 expression correlated with tumor progression, poor prognosis and drug resistance [14-16]. The gene discussed is CAV1; the disease is neoplasm.